论文部分内容阅读
目的 YKL-40,a novel COPD biomarker,participates in inflammatory responses and promotes angiogenesis.The study aimed toevaluate the correlations of serum YKL-40 levels with clinical disease severity and laboratory parameters of COPD and to assessthe associations of YKL-40 with IL-6 and VEGF.